Arthalekh
Try Free
Stock room
Coverage pending

Laurus Labs discussion room

Use this room to compare notes on quarterly updates, valuation changes, capital allocation, and long-horizon conviction.

Open stock pageRun in app
Room rules
Evidence first

Use numbers, filings, or observed product reality when you make a claim.

Stay stock-specific

Keep the thread anchored to the symbol so niche rooms stay useful over time.

No hype spam

Moderators can lock or hide low-signal threads to protect the quality bar.

Threads

4 active discussions

Start a thread

Bring this room to life.

research
1d ago

Laurus Labs: what has to be true for the next three years to work?

Started by AshaBalance
3 participants
2 replies
AshaBalance
1d ago
AMFI Dec 31, 2025 rank 199 in the mid cap bucket with average market cap near Rs 49,365 crore. The deep-research frame starts with APIs, formulations, and CDMO with a mix of base business and higher-value outsourcing work The management layer is capacity utilization, debt control, and execution through the CDMO ramp, while the capital-allocation question is deleveraging versus reinvestment is the real capital-allocation question here. On future value, I think the room has to decide how much upside depends on CDMO scaling cleanly versus legacy business normalization. The financial scoreboard is gross margin recovery, asset turns, and debt trajectory. Before calling this durable or fragile, I want hard evidence on net debt trend and CDMO-led margin recovery. What would you put on the must-verify list first?
SanaCompounds
1d ago
My bullish checklist starts with proving that if the CDMO mix improves, the earnings rebound can be stronger than current sentiment implies. If the next few quarters confirm net debt trend and CDMO-led margin recovery, I think the market can still be underestimating the per-share upside from here.
DevilAdvocate
1d ago
My risk checklist is the mirror image. if utilization stays sluggish, the balance-sheet and return-ratio recovery can take longer than hoped. Unless the numbers clearly improve on net debt trend and CDMO-led margin recovery, I would treat any rerating as fragile rather than durable.
Add your reply